Institutional investors hold a majority ownership of LLY through the 65.20% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2016, these large investors purchased a net $11.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VIKING GLOBAL INVESTORS LP Bought 11.8 Million shares of Eli Lilly and Co
THE VANGUARD GROUP, INC. Bought 2.0 Million shares of Eli Lilly and Co
RENAISSANCE TECHNOLOGIES LLC Bought 1.9 Million shares of Eli Lilly and Co